DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Minerva Neurosciences, Inc (NERV)
« Back to company indexNERV Chatter Timeline
Stock Ticker for NERV
Most Active Tweeters for NERV
| User | Tweets |
|---|---|
| @thefinreviewer | 8 |
| @BlogYomi | 4 |
| @UlmHi | 4 |
| @bulletin_en | 2 |
| @jeromeverony | 2 |
Recent Tweets for NERV
 |
@thefinreviewer Crinetics Pharmaceuticals Inc. $NERV Contrasting side by side https://t.co/BJWXUAGjbb April 18th 2019, 5:04pm |
 |
@bulletin_en Reviewing Pfenex Inc. $NERV's results https://t.co/aksHVlthSy April 18th 2019, 1:04am |
 |
@jeromeverony RT @SeekingAlpha: $NERV - Minerva Neurosciences: A Lacklustre Proposition All Around https://t.co/cVub67zEff April 17th 2019, 3:04pm |
|
@jeromeverony Minerva Neurosciences: A Lacklustre Proposition All Around $NERV https://t.co/MvHCprVaFT April 17th 2019, 2:04pm |
 |
@SeekingAlpha $NERV - Minerva Neurosciences: A Lacklustre Proposition All Around https://t.co/cVub67zEff April 17th 2019, 2:04pm |
 |
@BlogYomi Minerva Neurosciences $NERV Share Price Rose While New Leaf Venture Partners Has Raised by $1.76 Million Its Holdin… https://t.co/yA1zilWGRR April 17th 2019, 12:04pm |
 |
@UlmHi New Leaf Venture Partners Continues to Hold Position in Minerva Neurosciences $NERV; Pfizer $PFE Shareholder First… https://t.co/pRwQZ2tjXX April 17th 2019, 8:04am |
 |
@Stock_News_Now $NERV: New SEC Filing for NERV: Form DEFA14A (No. 0001193125-19-108372): https://t.co/FYw6uvhoJv April 17th 2019, 8:04am |
 |
@Biotech_Beast $NERV's roluperidone is set to produce results from a phase 3 trial in negative symptoms of schizophrenia in mid-20… https://t.co/3BCnYZ9IQP April 17th 2019, 8:04am |
 |
@BioPharmInsight What are $NERV’s MIN-101 Phase III schizophrenia trial prospects? @ShaunSim asks experts if the trial design and MO… https://t.co/XKUQ0sFfEl April 17th 2019, 7:04am |
 |
@StockTexts $NERV Minerva Neurosciences, Inc SEC Filing: Form DEFA14A https://t.co/dKVtEuCXk1 April 17th 2019, 7:04am |
 |
@xiscan1 #ValueInvesting $NERV Analysis via: @SeekingAlpha $NERV - A Look At The Competitors To Minerva's Roluperidone https://t.co/RLLzIivmkP April 17th 2019, 6:04am |
|
@SeekingAlpha $NERV - A Look At The Competitors To Minerva's Roluperidone https://t.co/VkeIcjmwMk April 17th 2019, 6:04am |
 |
@macondailynews Minerva Neurosciences $NERV Downgraded to “Hold” at ValuEngine https://t.co/RTfyFao3QW April 17th 2019, 2:04am |
|
@UlmHi 22nd Century Group Inc. $NERV Comparing side by side https://t.co/M6KkBqD7lh April 16th 2019, 11:04pm |
|
@thefinreviewer As Minerva Neurosciences $NERV Market Value Rose, New Leaf Venture Partners Has Raised by $1.76 Million Its Stake;… https://t.co/xXenC6acui April 16th 2019, 5:04am |
 |
@WeekHerald Minerva Neurosciences $NERV Downgraded by ValuEngine https://t.co/csY9ZsDTaa April 16th 2019, 2:04am |
 |
@ThisLincolnian ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/vjNaHOfH6W April 16th 2019, 2:04am |
|
@thefinreviewer Biohaven Pharmaceutical Holding Company Ltd. $NERV Comparison side by side https://t.co/iVtH258FQN April 16th 2019, 2:04am |
|
@thefinreviewer Reviewing Gamida Cell Ltd. $NERV's results https://t.co/u3No1upRVC April 16th 2019, 1:04am |
|
@UlmHi Contrasting of Corbus Pharmaceuticals Holdings Inc. $NERV https://t.co/kcR6G8ETV9 April 15th 2019, 10:04pm |
 |
@bibeypost_stock Today Minerva Neurosciences, Inc. $NERV Stock Rises https://t.co/PW4Es6cIgu April 15th 2019, 3:04pm |
 |
@dispatchtribune ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/UGwcjIXR39 April 15th 2019, 1:04am |
 |
@EnterpriseLeade ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/ppiyKDDhou April 15th 2019, 1:04am |
 |
@registrarjourn ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/FEVvJK7P7g April 15th 2019, 1:04am |
 |
@dakotafinancial Minerva Neurosciences $NERV Downgraded by ValuEngine https://t.co/4MiXd2OaP5 April 14th 2019, 10:04am |
|
@thefinreviewer Odonate Therapeutics Inc. $NERV https://t.co/tmzG69PmxQ April 13th 2019, 11:04pm |
 |
@mmahotstuff1 Could Minerva Neurosciences, Inc. $NERV Gain Strenght? The Stock Reaches 1 Year Low https://t.co/fEAjN982lf April 13th 2019, 2:04pm |
 |
@whatsonthorold2 Minerva Neurosciences, Inc. $NERV Stock Price Declines Today https://t.co/TZ374G3stX April 13th 2019, 2:04pm |
 |
@VM1409 RT @StockNewsWires: $NERV: Minerva withdraws filing for $200M mixed shelf: https://t.co/a1lMfZdzUG April 11th 2019, 6:04pm |
 |
@StockNewsWires $NERV: Minerva withdraws filing for $200M mixed shelf: https://t.co/a1lMfZdzUG April 11th 2019, 4:04pm |
 |
@Nonfiction8879 Minerva withdraws filing for $200M mixed shelf $NERV https://t.co/cSIJwtsQb4 April 11th 2019, 4:04pm |
 |
@MarketCurrents $NERV - Minerva withdraws filing for $200M mixed shelf https://t.co/CufZd3znjG April 11th 2019, 4:04pm |
 |
@Jon12508683 if $nerv drug works for negative symptoms of schizophrenia, stock will be much higher. but that’s a big if. April 11th 2019, 11:04am |
 |
@Briefingcom $NERV: Minerva Neurosciences presents pre-clinical data suggesting a mechanistic role of roluperidone in addressing… https://t.co/NGA15ScRnZ April 11th 2019, 10:04am |
|
@thefinreviewer Jaguar Health Inc. $NERV Contrasting side by side https://t.co/JInfPk1KXa April 11th 2019, 3:04am |
 |
@biopadawan @path1finder $nerv u positive about coming data in April? April 10th 2019, 1:04pm |
|
@UlmHi Vital Therapies Inc. $NERV https://t.co/JG41Poxccb April 10th 2019, 12:04pm |
|
@thefinreviewer California State Teachers Retirement System Holds Holding in Schlumberger LTD $SLB; Minerva Neurosciences $NERV Sha… https://t.co/8eCD0F3UOi April 10th 2019, 5:04am |
 |
@reurope_stock Minerva Neurosciences Inc $NERV Has Increase in Shorts https://t.co/hGQyqJ8RHz April 9th 2019, 3:04pm |
 |
@path1finder added additional positions in $NERV and $RVNC today April 9th 2019, 2:04pm |
|
@BlogYomi New Leaf Venture Partners Raised Minerva Neurosciences $NERV Position; As Service Intl $SCI Stock Declined, Td Asse… https://t.co/N674VGCkyA April 9th 2019, 6:04am |
|
@BlogYomi Highland Capital Management LP Has Lowered Its Stake in Minerva Neurosciences $NERV by $1.69 Million as Market Valu… https://t.co/DRRrWmbCSn April 8th 2019, 12:04pm |
|
@BlogYomi Comparing of Zai Lab Limited $NERV https://t.co/eoo6PWgqV0 April 8th 2019, 11:04am |
|
@bulletin_en Sphera Funds Management LTD Has Cut Its Position in Minerva Neurosciences $NERV by $362,238 as Stock Price Rose; As… https://t.co/N2PC1rJNJI April 7th 2019, 9:04am |
 |
@ConsumerFeed Zacks: Brokerages Expect Minerva Neurosciences Inc $NERV to Post -$0.35 Earnings Per Share https://t.co/Q6bEGXmMLY April 6th 2019, 3:04pm |
|
@thefinreviewer Comparing of Aquestive Therapeutics Inc. $NERV https://t.co/P2BXkhReuz April 6th 2019, 3:04am |
|
@BlogYomi Reviewing Gossamer Bio Inc. $NERV's results https://t.co/Z4R7nLtsli April 5th 2019, 7:04pm |
|
@dakotafinancial -$0.35 EPS Expected for Minerva Neurosciences Inc $NERV This Quarter https://t.co/SIode1yZsc April 4th 2019, 11:04pm |
|
@bulletin_en Reviewing iBio Inc. $NERV's results https://t.co/UDwy0nRA97 April 4th 2019, 8:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.